Advertisement

DNA test can identify pneumonia in patients with severe Covid

Follow The Hawk on Google News+ Follow

Advertisement


London: Researchers have developed a DNA test to quickly identify secondary infections in Covid-19 patients, who have double the risk of developing pneumonia while on ventilation.

For patients with the most severe forms of Covid-19, mechanical ventilation is often the only way to keep them alive, as doctors use anti-inflammatory therapies to treat their inflamed lungs.

Advertisement

However, these patients are susceptible to further infections from bacteria and fungi that they may acquire while in hospital -- so called 'ventilator-associated pneumonia'.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"Early on in the pandemic, we noticed that Covid-19 patients appeared to be particularly at risk of developing secondary pneumonia, and started using a rapid diagnostic test that we had developed for just such a situation," said co-author Andrew Conway Morris from the University of Cambridge.

"Using this test, we found that patients with Covid-19 were twice as likely to develop secondary pneumonia as other patients in the same intensive care unit," Conway added.

Advertisement

Normally, confirming a pneumonia diagnosis is challenging, as bacterial samples from patients need to be cultured and grown in a lab, which is time-consuming.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

The test takes an alternative approach by detecting the DNA of different pathogens, which allows for faster and more accurate testing, according to a paper published in the journal Critical Care.

The test uses multiple polymerase chain reaction (PCR) which detects the DNA of the bacteria and can be done in around four hours, meaning there is no need to wait for the bacteria to grow.

IT runs multiple PCR reactions in parallel, and can simultaneously pick up 52 different pathogens, which often infect the lungs of patients in intensive care. At the same time, it can also test for antibiotic resistance.

"We found that although patients with Covid-19 were more likely to develop secondary pneumonia, the bacteria that caused these infections were similar to those in ICU patients without Covid-19," said lead author Mailis Maes from the varsity.

"This means that standard antibiotic protocols can be applied to Covid-19 patients," Maes added.

—IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST